KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $14.1 billion.

  • Edwards Lifesciences' Retained Earnings rose 1070.23% to $14.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 billion, marking a year-over-year increase of 1070.23%. This contributed to the annual value of $13.2 billion for FY2024, which is 4642.36% up from last year.
  • Latest data reveals that Edwards Lifesciences reported Retained Earnings of $14.1 billion as of Q3 2025, which was up 1070.23% from $13.9 billion recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Retained Earnings high stood at $14.1 billion for Q3 2025, and its period low was $4.9 billion during Q1 2021.
  • In the last 5 years, Edwards Lifesciences' Retained Earnings had a median value of $8.2 billion in 2023 and averaged $9.0 billion.
  • As far as peak fluctuations go, Edwards Lifesciences' Retained Earnings soared by 4823.31% in 2024, and later skyrocketed by 1070.23% in 2025.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Retained Earnings stood at $6.1 billion in 2021, then increased by 25.08% to $7.6 billion in 2022, then rose by 18.48% to $9.0 billion in 2023, then skyrocketed by 46.42% to $13.2 billion in 2024, then increased by 7.46% to $14.1 billion in 2025.
  • Its last three reported values are $14.1 billion in Q3 2025, $13.9 billion for Q2 2025, and $13.5 billion during Q1 2025.